| Literature DB >> 35627657 |
Qin Yang1, Kun Wang2, Qianqian Tian3,4, Jian Zhang1, Linyu Qi1, Tao Chen5.
Abstract
OBJECTIVE: To study the effect of diet- and exercise-based lifestyle intervention on weight loss (WL) and cardiovascular risk among metabolically healthy obese (MHO) and metabolically unhealthy obese (MUO) children and adolescents.Entities:
Keywords: children and adolescents; diet; exercise; metabolically healthy obesity; obesity; weight loss
Mesh:
Substances:
Year: 2022 PMID: 35627657 PMCID: PMC9141466 DOI: 10.3390/ijerph19106120
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Basic characteristics of subjects who met the MHO/MUO criteria for children and adolescents in this study.
| Variable | MHO | MUO | Total | |
|---|---|---|---|---|
| N (%) | 102 (36.2%) | 180 (63.8%) | 282 (100%) | / |
| Age (y) | 12.4 ± 2.3 | 13.2 ± 2.2 | 12.9 ± 2.3 | 0.010 |
| Sex (M/F) | 49/53 | 102/78 | 151/131 | 0.163 |
| Height (cm) | 159.7 ± 11.5 | 163.9 ± 10.4 | 162.4 ± 11.0 | 0.002 |
| BW (kg) | 75.2 ± 18.1 | 85.3 ± 19.3 | 81.7 ± 19.4 | <0.001 |
| BMI (kg/m2) | 29.0 ± 3.8 | 31.4 ± 4.6 | 30.5 ± 4.5 | <0.001 |
| WC (cm) | 93.8 ± 11.1 | 99.4 ± 11.1 | 97.4 ± 11.4 | <0.001 |
Data are presented as mean ± SD. p value means comparison of variables between MHO and MUO group. N, number; M/F, male/female; BW, body weight; WC, waist circumference.
Distribution of metabolically healthy indicators in MHO and MUO groups before and after intervention.
| Variable | MHO Group ( | MUO Group ( | ||
|---|---|---|---|---|
| Before (%) | After (%) | Before (%) | After (%) | |
| MUO status | 0 (0.0%) | 36 (35.3%) | 180 (100%) | 112 (62.2%) |
| BMI > 95th percentile 1 | 102 (100%) | 94 (92.2%) | 180 (100%) | 164 (91.1%) |
| HDL-C ≤ 1.03 mmol/L | 0 (0.0%) | 29 (28.4%) | 76 (42.2%) | 102 (56.7%) |
| TG > 1.7 mmol/L | 0 (0.0%) | 0 (0.0%) | 22 (12.2%) | 2 (1.1%) |
| SBP > 90th percentile 1 | 0 (0.0%) | 7 (6.9%) | 117 (65.0%) | 36 (20.0%) |
| DBP > 90th percentile 1 | 0 (0.0%) | 6 (5.9%) | 88 (48.9%) | 32 (17.8%) |
| FBG > 5.6 mmol/L | 0 (0.0%) | 1 (1.0%) | 3 (1.7%) | 0 (0.0%) |
1 Age- and sex-specific percentiles, for blood pressure, also height-specific. MHO, metabolically healthy obesity; MUO, metabolically unhealthy obesity; WL, weight loss; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose.
Changes of anthropometry and blood indicators in MHO and MUO groups before and after intervention.
| Variable | MHO | MUO | |||||
|---|---|---|---|---|---|---|---|
| Before | After | Change% (95% CI) | Before | After | Change% (95% CI) | ||
| BW (kg) | 75.2 ± 18.1 | 68.3 ± 16.5 †,** | −9.2 (−9.5, −8.9) | 85.3 ± 19.3 | 77.3 ± 17.6 §,** | −9.5 (−9.8, −9.2) | 0.317 |
| BMI (kg/m2) | 29.0 ± 3.8 | 26.3 ± 3.5 †,** | −9.3 (−9.6, −9.0) | 31.4 ± 4.6 | 28.4 ± 4.3 §,** | −9.7 (−10.0, −9.4) | 0.077 |
| BFR (%) | 40.0 ± 4.7 | 35.6 ± 5.6 †,** | −11.1 (−12.7, −9.6) | 40.2 ± 5.5 | 35.5 ± 6.5 §,** | −11.9 (−13.1, −10.7) | 0.292 |
| WC (cm) | 93.8 ± 11.1 | 84.4 ± 10.4 †,** | −9.9 (−11.0, −8.9) | 99.4 ± 11.1 | 89.8 ± 10.6 §,** | −9.56 (−10.3, −8.8) | 0.357 |
| SBP (mmHg) | 107.5 ± 7.9 | 103.0 ± 9.5 †,** | −3.9 (−5.8, −1.9) | 124.8 ± 14.9 | 111.3 ± 13.5 §,** | −10.2 (−11.8, 8.6) | <0.001 |
| DBP (mmHg) | 64.7 ± 6.4 | 62.3 ± 9.4 †,** | −2.9 (−6.2, 0.4) | 77.6 ± 14.8 | 65.7 ± 11.8 §,** | −13.5 (−16.1, −10.8) | <0.001 |
| RHR (beats/min) | 88.9 ± 10.6 | 81.1 ± 11.9 †,** | −8.3 (−10.7, −6.0) | 93.1 ± 13.7 | 81.6 ± 13.1 §,** | −11.1 (−13.6, −8.7) | 0.025 |
| FBG (mmol/L) | 4.6 ± 0.4 | 4.5 ± 0.4 | −0.5 (−2.4, 1.4) | 4.6 ± 0.4 | 4.4 ± 0.4 §,** | −3.2 (−4.6, −1.8) | 0.011 |
| TG (mmol/L) | 0.8 ± 0.2 | 0.7 ± 0.2 †,** | −8.1 (−12.3, −3.9) | 1.1 ± 0.6 | 0.8 ± 0.3 §,** | −18.4 (−22.4, −14.5) | <0.001 |
| TC (mmol/L) | 4.4 ± 0.7 | 3.5 ± 0.6 †,** | −19.4 (−21.5, −17.3) | 4.5 ± 1.0 | 3.5 ± 0.6 §,** | −20.0 (−21.6, −18.4) | 0.670 |
| HDL-C (mmol/L) | 1.3 ± 0.2 | 1.2 ± 0.2 †,** | −8.6 (−10.8, −6.3) | 1.1 ± 0.3 | 1.1 ± 0.2 §,** | −6.2 (−8.0, −4.4) | 0.121 |
| LDL-C (mmol/L) | 2.6 ± 0.6 | 0.4 ± 0.6 †,** | −26.1 (−28.7, −23.6) | 2.9 ± 0.7 | 1.0 ± 0.8 §,** | −26.7 (−28.5, −24.8) | 0.730 |
Data presented as the group means ± SD. ** p < 0.01. “†” and “§” mean comparison between before- and after-intervention in MHO group and MUO group, respectively. p value means comparison of percent changes in variables between MHO and MUO group. Baseline levels of dependent variables were adjusted for each ANCOVA analysis. For analysis of BW and blood pressure, age, sex, and height were also adjusted. For analysis of BMI, age and sex were also adjusted. For analysis of WC, age, sex, and BMI were also adjusted. BW, body weight; BMI, body mass index; BFR, body fat ratio; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; RHR, resting heart rate; FBG, fasting blood glucose; TG, triglycerides; TC, total cholesterol; HDL-C, high-density lipoprotein–cholesterol; LDL-C, low-density lipoprotein–cholesterol.